Maxcyte (DI) (MXCT)

Index:

FTSE AIM 100

266.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 420.00
  • 52 Week Low: 262.00
  • Currency: UK Pounds
  • Shares Issued: 105.43m
  • Volume: 47,020
  • Market Cap: £280.46m
  • Beta: 0.36

Maxcyte (DI) Overview

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners’ challenges by applying our expertise.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -117.0% -143.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 8.6 7.5
Pr/Book 1.5  
Latest F'cast
Revenue -60.9% -27.7%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Maxcyte (DI) Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 21.62 (12.89) (23.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-20 26.00 (11.82) (17.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 33.89 (19.08) (21.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 44.26 (23.57) (54.87)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 41.29 (37.92) (37.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Maxcyte (DI) Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 37.57 (53.72) (32.62)p n/a n/a n/a n/a 0.0%
31-Dec-25 45.55 (47.89) (31.03)p n/a n/a n/a n/a 0.0%
31-Dec-26 57.21 (47.26) (33.28)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Maxcyte (DI) Company Announcements

Holding(s) in Company 19-Nov-2024 09:49 RNS
Filing of 10Q form 07-Nov-2024 07:00 RNS
Third Quarter 2024 Financial Results 07-Nov-2024 07:00 RNS

Maxcyte (DI) ShareCast News

MaxCyte appoints new chief commercial officer 10-Oct-2024 ShareCast
MaxCyte enters licence agreement with Kamau Ther... 16-Sep-2024 ShareCast
MaxCyte reports solid second-quarter performance 07-Aug-2024 ShareCast

Latest Maxcyte (DI) Director Deals

Traded Action Notifier PriceAmountValue
01-Nov-24 Sell Stan Erck 287.43p 47,689 £137,070.60
01-Nov-24 Exercise of option Stan Erck 3.09p 47,689 £1,475.58
28-Oct-24 Sell John Johnston 287.00p 3,000 £8,609.86

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 266.00p
Change Today 4.00p
% Change 1.53 %
52 Week High 420.00
52 Week Low 262.00
Volume 47,020
Shares Issued 105.43m
Market Cap £280.46m
Beta 0.36

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
17:05 3,000 @ 266.00p
17:05 484 @ 266.00p
16:20 3,000 @ 269.20p
16:19 484 @ 266.50p
16:18 1,460 @ 263.00p

Top of Page